NURS FPX 6016 Assessment 2 Quality Improvement Initiative Evaluation
Nurses gain understanding and trust in recognizing the situations that cause MAE and utilizing theoretical expertise in practice to resolve ADEs. This strategy reduces the incidence of MAEs, promotes patient satisfaction, and minimizes the expense of additional treatments for ADE-caused harm (Musharyanti et al., 2021). Other measures included efforts to prevent verbal prescribing. Verbal instructions and prescriptions should be avoided wherever possible and utilized only in extreme cases like emergencies (Ambwani et al., 2019).
Furthermore, developing regulations to follow the double-checking and drug reconciliation guidelines will aid in minimizing MAEs and, eventually, ADEs (Stralen et al., 2024). Moreover, Electronic Health Records (EHR), and the Barcode Scanning System (BCMA) play significant roles in reducing ADE during patient care. EHR systems will improve collaboration among interdisciplinary teams. EHR reconciliation functions will guide nurses in avoiding errors. Moreover, BCMA will support nurses in addressing five drug rights and preventing MAEs, improving patient safety (Naseralallah et al., 2023).
Knowledge Gaps and Missing Information
Although the QI initiative covers critical aspects, specific possible issues may remain unresolved. For example, the initiative may need to investigate underlying fundamental problems causing workflow inefficiencies extensively. The QI initiative focuses on developing medication security standards and interventions to establish a safety culture in the Henry Ford Hospital. However, this initiative has a drawback in that it fails to address the problem of ADE insufficient reporting. Furthermore, the endeavor may require a thorough strategy for dealing with misinterpretation or imprecise verbal prescriptions, which may continue to pose hazards to patient safety despite the execution of established protocols.
Furthermore, the QI strategy does not address staff scarcity, a significant risk factor for adverse drug practices (Salar et al., 2023). However, there is a knowledge gap; for better comprehension of MAEs’ background and the implications of the initiatives, there is a need to gather relevant data from the medical databases. Data regarding ADE prevalence and current medical centers’ initiatives to mitigate ADE incidences aid in evaluation before and after the QI actions for ADE prevention (Naseralallah et al., 2023). To analyze the effectiveness of the current QI endeavor, sensitive and reliable outcome metrics must be used.
NURS FPX 6016 Assessment 2 Quality Improvement Initiative Evaluation
These outcome metrics must include lowering MAE, near misses, and ADEs and improving compliance with pharmaceutical safety guidelines. It increases medical staff expertise and evaluates patient satisfaction with pharmaceutical delivery protocols (Musharyanti et al., 2021). By carefully analyzing these outcome metrics, the QI initiative’s impact on patient safety and the quality of care can be measured, and areas for reform can be uncovered. The QI endeavor is a proactive approach to deal with the ADE and improve patient safety at Henry Ford Hospital. Additional information, refinement, or review may be required to guarantee its success and sustainability.
Evaluation of the Success of the Quality Improvement Initiative
To determine the effectiveness of a healthcare QI strategy, it must be monitored and analyzed frequently. The Henry Ford Hospital management examined the QI program implemented in their healthcare setting to avoid ADEs related to MAEs. The Agency for Healthcare Research and Quality (AHRQ) highlighted three areas of analysis for the QI program, including tracking the compliance with the new strategies, assessing the impact of new approaches in providing patient-focused care, and evaluating the enhancements in patient satisfaction and standard of care (Mikhael et al., 2023).
This evaluation is based on the total number of patients enrolled in a Henry Ford Hospital and the implementation plan’s participants, including physicians, nurses, pharmacists, and patients. This initiative’s Key Performance Indicators (KPIs) include fewer MAEs and adverse events, improved conformity to drug safety guidelines, and increased patient satisfaction with the administration of drug processes. These metrics are critical for meeting accreditation requirements and providing standard patient care (Lima et al., 2019). It is evaluated that the QI initiative’s strategies substantially benefit patient safety outcomes regarding ADEs. Interprofessional education and training result in healthcare professionals’ co